CLINICAL OUTCOMES AFTER BARE-METAL STENTS DEPLOYMENT IN LARGE CORONARY ARTERIES IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION

During percutaneous coronary intervention (PCI) in the emergency setting of ST-segment elevation myocardial infarction (STEMI), whether patients can comply with 12 months dual anti-platelet therapy after drug-eluting stenting (DES), is often uncertain. Thus if bare-metal stent (BMS) deployment could